| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rezolute, Inc. (RZLT) has 10 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. RZLT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 641.1K | $3.30M | - | |
| Other | 308.4K | $1.59M | - | |
| ? | 170.9K | $880.4K | - | |
| ? | 119.7K | $616.3K | - | |
| Other | 71.5K | $368.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Elam Nevan C76 | CEO | Buy | 5,000 | $1.68 | $8,400.00 | +177.5% | +125.0% | +154.9% | |
| Feb 26, 2024 | Roberts Brian Kenneth79 | Chief Medical Officer | Buy | 8,000 | $1.69 | $13,540.00 | +10.7% | +125.0% | +154.9% | |
| Feb 16, 2024 | Evans Daron81 | CFO | Buy | 50,900 | $1.31 | $66,741.34 | +175.5% | +89.6% | +241.5% | |
| Feb 16, 2024 | Roberts Brian Kenneth79 | Chief Medical Officer | Buy | 7,000 | $1.31 | $9,142.00 | +25.4% | +89.6% | +241.5% | |
| Jul 3, 2023 | Roberts Brian Kenneth79 | Chief Medical Officer | Buy | 5,000 | $1.90 | $9,499.50 | +22.2% | -38.8% | +107.9% | |
| Jul 22, 2022 | Handok, Inc. | - | Buy | 3,927,126 | $4.33 | $17,000,002.50 | +81.8% | -30.8% | -35.7% | |
| May 19, 2022 | Roberts Brian Kenneth79 | Sr VP, Clinic Development | Buy | 1,500 | $3.24 | $4,862.25 | +2.3% | +6.3% | -28.7% | |
| May 4, 2022 | Roberts Brian Kenneth79 | Sr VP, Clinic Development | Buy | 21,052 | $3.80 | $79,997.60 | New | -16.4% | -43.5% | |
| May 4, 2022 | Labrucherie Gil M84 | Director | Buy | 52,631 | $3.80 | $199,997.80 | New | -16.4% | -43.5% | |
| May 4, 2022 | Hogenhuis Wladimir47 | Director | Buy | 32,693 | $4.44 | $145,004.50 | +425.0% | -16.4% | -43.5% |